Thus, in this article, we analyzed the DNA methylation distribution and variation in genome-wide and mRNA transcription profiles in CD4+ T cells from proliferative LN patients and SLE patients without kidney injury compared to healthy controls to identify potential biomarkers for LN. This evidence concerns the gene CD4 and systemic lupus erythematosus.